Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer | Newswise
Newswise — Boston – Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine. The vaccines were administered after surgery to remove…